Click here to close now.




















Welcome!

News Feed Item

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

LONDON, Jan. 6, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:

Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018

The cell surface markers market is undergoing impressive growth across the globe due to rapid automation of technologies and solutions, simplification of data management coupled with increasing preference for reduction of healthcare spending with a view to provide rapid and efficient decision making for therapies for specific diseases. On the other hand, high prevalence of chronic diseases such as cancer and autoimmune disorders has resulted in an elevated demand for cell surface markers analysis worldwide. Since their introduction, cell surface makers study has undergone tremendous technological development, and it is expected that soon end-users will be benefited from the increasing scope of applications of cell surface markers.

This report studies the cell surface markers market by the types of products commercially available for cell markers analysis. Each of the segments has been analyzed on the basis of its current and future market size for the period 2011 to 2019, in terms of revenue generation in USD million. The CAGR (%) of all segments has been provided for the forecast period of 2013 to 2019, considering 2012 as the base year.

In terms of geography, this market has been classified into North America, Europe, Asia-Pacific and Rest of the World (RoW) regions. The respective market size for each region and their forecast till 2019 has also been presented in the report. In addition, a qualitative assessment of the market dynamics of the cell surface markers market has been provided, wherein the drivers, restraints, opportunities and market attractiveness has been studied.

The competitive landscape section of this report provides a bird's eye view of the major market players currently operating in this market and their respective products. Also, a pipeline snapshot of new entrants in this market along with their development stage products has been included. Some of the key market players profiled in this report include Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., Grifols SA, Immucor, Inc. and Janssen Diagnostics, Inc.

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.4 List of Abbreviations

Chapter 2 Executive Summary

Chapter 3 Market Overview
3.1 Market Trends and Future Outlook
3.2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
3.3 Drivers
3.3.1 Growing Automation in Laboratories
3.3.2 Discovery of New Markers will Need New Antibodies
3.3.3 Increased Use of In Vitro Diagnostics
3.3.4 Need for Lowering Healthcare Expenditure
3.4 Restraints
3.4.1 Reluctance for High Investment in Sophisticated Models
3.4.2 Complexity in the Use of Flow Cytometers
3.5 Opportunities
3.5.1 Growth in Expertise for Operation of Cell Marking Tools
3.5.2 Targeted Therapy and Personalized Medicine
3.6 Porter's Five Force Analysis for the Global Cell Surface Markers Market
3.6.1 Bargaining Power of Suppliers
3.6.2 Bargaining Power of Buyers
3.6.3 Threat of New Entrants
3.6.4 Threat of Substitutes
3.6.5 Competitive Rivalry
3.7 Market Attractiveness Analysis of Global Cell Surface Markers Market, by Instruments and Reagents, 2012

Chapter 4 Global Cell Surface Markers Market, by Instruments and Reagents
4.1 Overview – Current Market Scenario and Future Market Trends
4.1.1 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
4.2 Flow Cytometry
4.2.1 Global Flow Cytometers Market Revenues, 2013 – 2019 (USD Million)
4.2.2 Global Flow Cytometers Market Volume, 2013 – 2019 (Number of Units Installed)
4.3 Hematology Analyzers
4.3.1 Global Hematology Analyzers Market Revenues, 2011 – 2019 (USD Million)
4.3.2 Global Hematology Analyzers Market Volume, 2013 – 2019 (Number of Units Installed)
4.4 Reagents and Kits
4.4.1 Global Reagent and Kits Market Revenues, 2011 – 2019 (USD Million)

Chapter 5 Global Cell Surface Markers Market, by Applications
5.1 Disease Diagnosis
5.1.1 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 – 2019 (USD Million)
5.2 Research and Drug Discovery
5.2.1 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 – 2019 (USD Million)

Chapter 6 Global Cell Surface Markers Market, by Geography
6.1 Introduction
6.2 North America
6.2.1 North America Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.3 Europe
6.3.1 Europe Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)
6.4 Asia-Pacific
6.4.1 Asia-Pacific Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
6.5 Rest of the World (RoW)
6.5.1 Rest of the World (RoW) Cell Surface Markers Market Revenues, Size and Forecast, 2011 – 2019 (USD Million)

Chapter 7 Recommendations

Chapter 8 Company Profiles
8.1 Abbott Laboratories, Inc.
8.1.1 Company Overview
8.1.2 Strategic Overview
8.1.3 Financial Overview
8.1.4 Product Portfolio
8.1.5 Recent Developments
8.2 Beckman Coulter, Inc.
8.2.1 Company Overview
8.2.2 Strategic Overview
8.2.3 Financial Overview
8.2.4 Product Portfolio
8.2.5 Recent Developments
8.3 BD Biosciences
8.3.1 Company Overview
8.3.2 Strategic Overview
8.3.3 Financial Overview
8.3.4 Product Portfolio
8.3.5 Recent Development
8.4 Bio-Rad Laboratories, Inc.
8.4.1 Company Overview
8.4.2 Strategic Overview
8.4.3 Financial Overview
8.4.4 Product Portfolio
8.4.5 Recent Development
8.5 Grifols SA
8.5.1 Company Overview
8.5.2 Strategic Overview
8.5.3 Financial Overview
8.5.4 Product Portfolio
8.5.5 Recent Development
8.6 Immucor, Inc.
8.6.1 Company Overview
8.6.2 Strategic Overview
8.6.3 Financial Overview
8.6.4 Product Portfolio
8.6.5 Recent Developments
8.7 Janssen Diagnostics, Inc.
8.7.1 Company Overview
8.7.2 Strategic Overview
8.7.3 Financial Overview
8.7.4 Product Portfolio
8.7.5 Recent development
8.8 Nihon Kohden Corporation
8.8.1 Company Overview
8.8.2 Strategic Overview
8.8.3 Financial Overview
8.8.4 Product Portfolio
8.8.5 Recent developments
8.9 F. Hoffmann-La Roche Ltd.
8.9.1 Company Overview
8.9.2 Strategic Overview
8.9.3 Financial Overview
8.9.4 Product Portfolio
8.9.5 Recent Developments
8.10 Siemens Healthcare
8.10.1 Company Overview
8.10.2 Strategic Overview
8.10.3 Financial Overview
8.10.4 Product Portfolio
8.10.5 Recent Developments
8.11 Sysmex Corporation
8.11.1 Company Overview
8.11.2 Strategic Overview
8.11.3 Financial Overview
8.11.4 Product Portfolio
8.11.5 Recent Development
8.12 Thermo Fischer Scientific, Inc.
8.12.1 Company Overview
8.12.2 Strategic Overview
8.12.3 Financial Overview
8.12.4 Product Portfolio
8.12.5 Recent Development

LIST OF FIGURES

FIG. 1 Cell Surface Markers: Market Segmentation
FIG. 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2012 (USD Million)
FIG. 3 Global Cell Surface Markers Market Revenues, by Geography, 2012 (USD Million)
FIG. 4 Porter's Five Force Analysis: Global Cell Surface Markers Market
FIG. 5 Market Attractive Analysis: Global Cell Surface Markers Market, by Instruments and Reagents, 2012
FIG. 6 Global Cell Surface Markers Market Revenues, 2011 – 2019 (USD Million)
FIG. 7 Global Flow Cytometers Market Revenues, 2011 - 2019 (USD Million)
FIG. 8 Global Flow Cytometers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 9 Global Hematology Analyzers Market Revenues, 2011 - 2019 (USD Million)
FIG. 10 Global Hematology Analyzers Market Volume, 2011 – 2019 (Number of Units Installed)
FIG. 11 Global Reagents and Kits Market Revenues, 2011 - 2019 (USD Million)
FIG. 12 Global Cell Surface Markers Market Revenues, by Disease Diagnosis and Identification, 2011 - 2019 (USD Million)
FIG. 13 Global Cell Surface Markers Market Revenues, by Research and Drug Discovery, 2011 - 2019 (USD Million)
FIG. 14 North America Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 15 Europe Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 16 Asia-Pacific Cell Surface Markers Market Revenues, 2011 - 2019(USD Million)
FIG. 17 Rest of the World (RoW) Cell Surface Markers Market Revenues, 2011 - 2019 (USD Million)
FIG. 18 Annual Revenues of Abbott Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 19 Annual Revenues of Bio-Rad Laboratories, Inc., 2010 – 2012 (USD Million)
FIG. 20 Annual Revenues of Grifols SA, 2010 – 2012 (USD Million)
FIG. 21 Annual Revenues of Immucor, Inc., 2010 – 2012 (USD Million)
FIG. 22 Annual Revenues of Nihon Kohden Corp., 2010 – 2012 (USD Million)
FIG. 23 Annual Revenues of Hoffmann-La Roche Ltd., 2010 – 2012 (USD Million)
FIG. 24 Annual Revenues of Siemens Healthcare, 2010 – 2012 (USD Million)
+FIG. 25 Annual Revenues of Sysmex Corporation, 2010 – 2012 (USD Million)
FIG. 26 Annual Revenues of Thermo Fischer Scientific, Inc., 2010 – 2012 (USD Million)

LIST OF TABLES

TABLE 1 Market Snapshot: Global Cell Surface Markers Market
TABLE 2 Global Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 3 Global Cell Surface Markers Market Revenues, by Geography, Size and Forecast, 2013-2019 (USD Million)
TABLE 4 North America Cell Surface Markers Market Revenues, by Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 5 Europe Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 6 Asia-Pacific Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)
TABLE 7 RoW Cell Surface Markers Market Revenues, By Instruments and Reagents, 2011 – 2019 (USD Million)

Read the full report:
Cell Surface Markers (Flow Cytometers, Hematology Analyzers, Reagents And Kits) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2012 - 2018
http://www.reportbuyer.com/pharma_healthcare/diagnostics/cell_surface_markers_flow_cytometers_hematology_analyzers_reagents_kits_market_global_industry_analysis_size_share_growth_trends_forecast_2012_2018.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=In_Vitro_Diagnostic

For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]  
Tel: +44 208 816 85 48
Website: www.reportbuyer.com

SOURCE ReportBuyer

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
In a recent research, analyst firm IDC found that the average cost of a critical application failure is $500,000 to $1 million per hour and the average total cost of unplanned application downtime is $1.25 billion to $2.5 billion per year for Fortune 1000 companies. In addition to the findings on the cost of the downtime, the research also highlighted best practices for development, testing, application support, infrastructure, and operations teams.
"We specialize in testing. DevOps is all about continuous delivery and accelerating the delivery pipeline and there is no continuous delivery without testing," noted Marc Hornbeek, Sr. Solutions Architect at Spirent Communications, in this SYS-CON.tv interview at @DevOpsSummit, held June 9-11, 2015, at the Javits Center in New York City.
How do you securely enable access to your applications in AWS without exposing any attack surfaces? The answer is usually very complicated because application environments morph over time in response to growing requirements from your employee base, your partners and your customers. In his session at @DevOpsSummit, Haseeb Budhani, CEO and Co-founder of Soha, shared five common approaches that DevOps teams follow to secure access to applications deployed in AWS, Azure, etc., and the friction an...
"Alert Logic is a managed security service provider that basically deploys technologies, but we support those technologies with the people and process behind it," stated Stephen Coty, Chief Security Evangelist at Alert Logic, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
Digital Transformation is the ultimate goal of cloud computing and related initiatives. The phrase is certainly not a precise one, and as subject to hand-waving and distortion as any high-falutin' terminology in the world of information technology. Yet it is an excellent choice of words to describe what enterprise IT—and by extension, organizations in general—should be working to achieve. Digital Transformation means: handling all the data types being found and created in the organizat...
The essence of cloud computing is that all consumable IT resources are delivered as services. In his session at 15th Cloud Expo, Yung Chou, Technology Evangelist at Microsoft, demonstrated the concepts and implementations of two important cloud computing deliveries: Infrastructure as a Service (IaaS) and Platform as a Service (PaaS). He discussed from business and technical viewpoints what exactly they are, why we care, how they are different and in what ways, and the strategies for IT to tran...
The Internet of Everything (IoE) brings together people, process, data and things to make networked connections more relevant and valuable than ever before – transforming information into knowledge and knowledge into wisdom. IoE creates new capabilities, richer experiences, and unprecedented opportunities to improve business and government operations, decision making and mission support capabilities.
The Software Defined Data Center (SDDC), which enables organizations to seamlessly run in a hybrid cloud model (public + private cloud), is here to stay. IDC estimates that the software-defined networking market will be valued at $3.7 billion by 2016. Security is a key component and benefit of the SDDC, and offers an opportunity to build security 'from the ground up' and weave it into the environment from day one. In his session at 16th Cloud Expo, Reuven Harrison, CTO and Co-Founder of Tufin,...
The Internet of Things is not only adding billions of sensors and billions of terabytes to the Internet. It is also forcing a fundamental change in the way we envision Information Technology. For the first time, more data is being created by devices at the edge of the Internet rather than from centralized systems. What does this mean for today's IT professional? In this Power Panel at @ThingsExpo, moderated by Conference Chair Roger Strukhoff, panelists addressed this very serious issue of pro...
With SaaS use rampant across organizations, how can IT departments track company data and maintain security? More and more departments are commissioning their own solutions and bypassing IT. A cloud environment is amorphous and powerful, allowing you to set up solutions for all of your user needs: document sharing and collaboration, mobile access, e-mail, even industry-specific applications. In his session at 16th Cloud Expo, Shawn Mills, President and a founder of Green House Data, discussed h...
Container technology is sending shock waves through the world of cloud computing. Heralded as the 'next big thing,' containers provide software owners a consistent way to package their software and dependencies while infrastructure operators benefit from a standard way to deploy and run them. Containers present new challenges for tracking usage due to their dynamic nature. They can also be deployed to bare metal, virtual machines and various cloud platforms. How do software owners track the usag...
Discussions about cloud computing are evolving into discussions about enterprise IT in general. As enterprises increasingly migrate toward their own unique clouds, new issues such as the use of containers and microservices emerge to keep things interesting. In this Power Panel at 16th Cloud Expo, moderated by Conference Chair Roger Strukhoff, panelists addressed the state of cloud computing today, and what enterprise IT professionals need to know about how the latest topics and trends affect t...
"Our biggest growth area has been the security services, the managed services - the things that differentiate us in the market that there is no client that's too small and there's no client that's too big," explained Paul Mazzucco, Chief Security Officer at TierPoint, in this SYS-CON.tv interview at 16th Cloud Expo, held June 9-11, 2015, at the Javits Center in New York City.
SYS-CON Events announced today that HPM Networks will exhibit at the 17th International Cloud Expo®, which will take place on November 3–5, 2015, at the Santa Clara Convention Center in Santa Clara, CA. For 20 years, HPM Networks has been integrating technology solutions that solve complex business challenges. HPM Networks has designed solutions for both SMB and enterprise customers throughout the San Francisco Bay Area.
Countless business models have spawned from the IaaS industry. Resell Web hosting, blogs, public cloud, and on and on. With the overwhelming amount of tools available to us, it's sometimes easy to overlook that many of them are just new skins of resources we've had for a long time. In his General Session at 16th Cloud Expo, Phil Jackson, Lead Technology Evangelist at SoftLayer, broke down what we've got to work with and discuss the benefits and pitfalls to discover how we can best use them to d...